Iepsen, Eva W. http://orcid.org/0000-0002-0880-8798
Zhang, Jinyi
Hollensted, Mette
Madsbad, Sten
Hansen, Torben
Holst, Jens J.
Jørgensen, Niklas R.
Holm, Jens-Christian
Torekov, Signe S.
Funding for this research was provided by:
Lundbeckfonden
Novo Nordisk Fonden
Aase og Ejnar Danielsens Fond
Augustinus Fonden
Article History
Received: 6 June 2019
Accepted: 16 July 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: TH hold stocks in Novo Nordisk A/S. JJH has acted as consultant and has received speaker honoraria for Novo Nordisk. SM served as a consultant or adviser to: Novartis Pharmaceuticals, Novo Nordisk, Merck, Sharp and Dome, Pfizer A/S, Abbott Laboratories, Sanofi Aventis, Astra Zeneca, Johnson & Johnson, Rosche, Mankind, BMS, Antarcia, Boehringer Ingelheim, Eli Lilly. Amgen Received fee for speaking: Novo Nordisk, Merck, Sharp and Dome, Astra Zeneca, Johnson and Johnson, Abbott Laboratories, Pfizer A/S, Roche, Schering-Plough, Sanofi-Aventis, Eli Lilly, Novartis Pharmaceuticals, BMS, Boehringer Ingelheim. The remaining authors have nothing to disclose.